Ju Wang

880 total citations
22 papers, 702 citations indexed

About

Ju Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ju Wang has authored 22 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Ju Wang's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (6 papers). Ju Wang is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (6 papers). Ju Wang collaborates with scholars based in China, Australia and Kazakhstan. Ju Wang's co-authors include Hao Chang, Zhihong Zhao, Chaomin Sun, Shan Kuang, Ge Liu, Quancai Peng, Shengfa Wang, Tao Wang, Yanli Li and Zhongliang Ma and has published in prestigious journals such as Journal of Hazardous Materials, The FASEB Journal and Chemosphere.

In The Last Decade

Ju Wang

22 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju Wang China 14 508 420 75 51 41 22 702
Juanjuan Xiao China 13 388 0.8× 194 0.5× 61 0.8× 44 0.9× 28 0.7× 31 572
Hongbin Huang China 12 327 0.6× 182 0.4× 119 1.6× 32 0.6× 27 0.7× 24 603
Chuangyu Wen China 18 506 1.0× 279 0.7× 113 1.5× 63 1.2× 43 1.0× 34 752
Jin Ma China 13 545 1.1× 139 0.3× 73 1.0× 85 1.7× 70 1.7× 43 839
Xiu Cheng China 12 264 0.5× 179 0.4× 53 0.7× 31 0.6× 27 0.7× 29 528
Hamada A. Mokhlis Egypt 10 311 0.6× 226 0.5× 63 0.8× 25 0.5× 30 0.7× 18 494
Zhiqin Fu China 12 254 0.5× 148 0.4× 96 1.3× 41 0.8× 18 0.4× 34 533
Gennady A. Belitsky Russia 15 402 0.8× 152 0.4× 114 1.5× 70 1.4× 27 0.7× 71 649

Countries citing papers authored by Ju Wang

Since Specialization
Citations

This map shows the geographic impact of Ju Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Wang more than expected).

Fields of papers citing papers by Ju Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Wang. The network helps show where Ju Wang may publish in the future.

Co-authorship network of co-authors of Ju Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ju Wang. A scholar is included among the top collaborators of Ju Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju Wang. Ju Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Zhening, Ju Wang, Xiao Li, et al.. (2025). Aberrant controllability of functional connectome during working memory tasks in patients with schizophrenia and unaffected siblings. The British Journal of Psychiatry. 227(1). 463–472. 2 indexed citations
2.
Pan, Sheng, et al.. (2024). MG149 suppresses anaplastic thyroid cancer progression by inhibition of lysine acetyltransferase KAT5-mediated c-Myc acetylation. Bulletin du Cancer. 112(2). 122–134. 1 indexed citations
3.
Li, Yuhong, Kaiyuan Zhang, Xuejiao Lei, et al.. (2021). Long Non−Coding RNA H19 Regulates Glioma Cell Growth and Metastasis via miR-200a-Mediated CDK6 and ZEB1 Expression. Frontiers in Oncology. 11. 757650–757650. 28 indexed citations
5.
Wang, Ju, et al.. (2020). Effects of multi-walled carbon nanotubes on the enantioselective toxicity of the chiral insecticide indoxacarb toward zebrafish (Danio rerio). Journal of Hazardous Materials. 397. 122724–122724. 21 indexed citations
6.
Wang, Yongqiang, Huimin Zhang, & Ju Wang. (2020). Discovery of a novel three-long non-coding RNA signature for predicting the prognosis of patients with gastric cancer. Journal of Gastrointestinal Oncology. 11(4). 760–769. 12 indexed citations
7.
Chang, Hao, et al.. (2019). Circular RNA circ_0026134 regulates non-small cell lung cancer cell proliferation and invasion via sponging miR-1256 and miR-1287. Biomedicine & Pharmacotherapy. 112. 108743–108743. 48 indexed citations
8.
Wang, Changhe, et al.. (2019). MiR-342-3p inhibits cell migration and invasion through suppressing forkhead box protein Q1 in ovarian carcinoma. Anti-Cancer Drugs. 30(9). 917–924. 9 indexed citations
10.
Wang, Huimin, Zhongliang Ma, Caiyan Zhang, et al.. (2019). MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN. Biomedicine & Pharmacotherapy. 111. 1103–1111. 60 indexed citations
11.
Jin, Weihua, et al.. (2018). Marine Bacterial Polysaccharide EPS11 Inhibits Cancer Cell Growth via Blocking Cell Adhesion and Stimulating Anoikis. Marine Drugs. 16(3). 85–85. 24 indexed citations
12.
Zhao, Zhihong, et al.. (2017). LncRNA CCAT2 promotes tumorigenesis by over-expressed Pokemon in non-small cell lung cancer. Biomedicine & Pharmacotherapy. 87. 692–697. 58 indexed citations
13.
Wang, Lei, et al.. (2017). MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line. Cancer Research and Treatment. 50(3). 936–949. 27 indexed citations
14.
Gao, Jian, et al.. (2015). Long non-coding RNA BANCR regulates growth and metastasis and is associated with poor prognosis in retinoblastoma. Tumor Biology. 36(9). 7205–7211. 76 indexed citations
15.
Wang, Ju, et al.. (2015). Correlation Between Mammograghic Findings and Clinical/Pathologic Features in Women with Small Invasive Breast Carcinomas. Asian Pacific Journal of Cancer Prevention. 15(24). 10643–10646. 4 indexed citations
16.
Zhang, Jian, et al.. (2014). Tanshinone IIA induces cytochrome c-mediated caspase cascade apoptosis in A549 human lung cancer cells via the JNK pathway. International Journal of Oncology. 45(2). 683–690. 36 indexed citations
17.
Wang, Dingding, Manman Su, Yan Sun, et al.. (2012). Expression, purification and characterization of a human single-chain Fv antibody fragment fused with the Fc of an IgG1 targeting a rabies antigen in Pichia pastoris. Protein Expression and Purification. 86(1). 75–81. 11 indexed citations
18.
Xia, Xing, Ying Pan, Zhen Ouyang, et al.. (2011). Pharmacokinetic-pharmacodynamic Modeling of Monoamine Oxidase A Inhibitory Activity and Behavior Improvement by Curcumin in the Mouse Forced Swimming Test. Chinese Journal of Natural Medicines. 9(4). 293–304. 6 indexed citations
19.
Wang, Ju. (2008). Correlation of the expression of pokemon with p14~(ARF) and bcl-2 and their effects on prognosis of non small cell lung cancer. Tumori. 2 indexed citations
20.
Zhao, Zhihong, Shengfa Wang, Yu Liang, et al.. (2008). Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Lung Cancer. 62(1). 113–119. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026